Search for: "Mylan Pharmaceuticals"
Results 101 - 120
of 738
Sorted by Relevance
|
Sort by Date
10 Mar 2019, 4:54 am
The invention protected by the patent owned by Eli Lilly relates to a highly selective phosphodiesterase (PDE) enzyme inhibitor and to its use in a pharmaceutical unit dosage form. [read post]
27 Oct 2006, 9:43 am
In Ortho-McNeil Pharmaceutical v. [read post]
30 Nov 2017, 5:26 am
Here is the amicus brief filed in Mylan Pharmaceuticals Inc. v. [read post]
25 Sep 2017, 3:59 am
Here is the brief in the matter captioned Mylan Pharmaceuticals Inc. v. [read post]
26 Feb 2018, 9:08 am
Here is the order in Mylan Pharmaceuticals v. [read post]
20 Jan 2022, 4:19 am
In denying petitions from consumer tech giant Apple and generic pharmaceutical firm Mylan Laboratories, SCOTUS has ended the latest challenge to the PTAB’s NHK/Fintiv rule, which has raised the ire of many entities who have found the PTAB to be a very valuable backdoor towards patent invalidation outside of U.S. district court. [read post]
4 Jan 2022, 6:00 am
Cir. 2021) 2021-1729 AstraZeneca AB and AstracZeneca Pharmacueticals LP (AstraZeneca) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
17 Mar 2022, 2:32 pm
Mylan Pharmaceuticals Inc. [read post]
21 Apr 2020, 6:30 am
Mylan Pharmaceuticals, Inc., the Federal Circuit reversed the District Court of New Jersey’s grant of summary judgement in favor of Valeant that claim 8 of U.S. [read post]
11 Dec 2020, 3:11 am
On 4 December 2020, the English Patents Court handed down its decision in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited, the main action proceedings regarding Neurim’s patent for Circadin, EP 1 441 702 (“EP 702”). [read post]
13 Mar 2013, 8:49 pm
Endo Pharmaceuticals v. [read post]
28 May 2012, 8:51 pm
• Defendants: Mylan Institutional LLC; Mylan... [read post]
3 Nov 2013, 9:55 pm
• Defendant: Mylan Pharmaceuticals Inc. [read post]
Hague District Court grants cross-border preliminary injunction against Mylan in Novartis SPC battle
22 Oct 2020, 8:23 am
In cases where the relevant pharmaceutical does not have orphan drug status, the duration of the SPC is extended by six months, pursuant to Article 36. [read post]
14 Jun 2011, 9:24 pm
• Defendants: Mylan Inc.; Mylan Pharmaceuticals, Inc. [read post]
20 Jul 2018, 8:18 am
Mylan Pharmaceuticals: 18-1638.opinion.7-20-2018 Briefs here. [read post]
7 Nov 2017, 11:04 am
Here is the order in Mylan Pharmaceuticals v. [read post]
22 Mar 2015, 9:46 pm
Mylan Pharmaceuticals, Inc. 1:15-cv-00049; filed March 19, 2015 in the Northern District of West Virginia Bristol-Myers Squibb Co. v. [read post]
11 Jan 2015, 9:59 pm
Mylan Inc. et al. 1:15-cv-00026; filed January 8, 2015 in the District Court of Delaware • Plaintiffs: Pfizer Inc.; Wyeth LLC; Pfizer Pharmaceuticals LLC; PF Prism C.V.; Pfizer Manufacturing Holdings LLC • Defendants: Mylan Inc.; Agila Specialties Private Ltd.; Mylan Pharmaceuticals Inc. [read post]
22 Mar 2015, 9:46 pm
Mylan Pharmaceuticals, Inc. 1:15-cv-00049; filed March 19, 2015 in the Northern District of West Virginia Bristol-Myers Squibb Co. v. [read post]
